In the first study, a retrospective case-control study of 123 gastric cancer cases (64 EBV-positive and 59 EBV-negative) and 73 controls in Japan, EBV-positive gastric cancer had higher seropositive rate of VCA-IgA than in EBV-negative gastric cancer. This evidence concerns the gene CD79A and gastric cancer.